Another Stab at Disease-Modifying OA Drug Hits Home in Early Study

(MedPage Today) -- Patients with osteoarthritis (OA) of the knee receiving an investigational chemokine inhibitor showed some improvements in pain and disability, said researchers with the drug's developer.
In a phase I study that also included...